Broccoli Sprouts for Mild Ulcerative Colitis

NCT ID: NCT05507931

Last Updated: 2026-01-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

23 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-23

Study Completion Date

2026-01-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to determine the number of servings of broccoli sprouts sufficient to (1) increase sulforaphane levels in the stool and blood and (2) reduce inflammatory markers in patients with mild ulcerative colitis. This is a pilot feasibility study to prepare for a larger randomized controlled trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ulcerative Colitis Ulcerative Colitis Chronic Mild

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1 Serving of broccoli sprouts

113 grams

Group Type EXPERIMENTAL

1 Serving of broccoli sprouts

Intervention Type DIETARY_SUPPLEMENT

Participants will take 1 serving of broccoli sprouts daily for 28 days. The sprouts will be provided by the study team along with instructions on how to prepare the steamed broccoli sprouts (i.e., steamed for 10 minutes). In addition to taking the sprouts, participants will be asked to complete food diaries and surveys, collect blood and stool samples, as well as having 2 in-person visits.

3 Servings of broccoli sprouts

339 grams

Group Type EXPERIMENTAL

3 Servings of broccoli sprouts

Intervention Type DIETARY_SUPPLEMENT

Participants will take 3 servings of broccoli a day for 28 days. The sprouts will be provided by the study team along with instructions on how to prepare the steamed broccoli sprouts (i.e., steamed for 10 minutes). In addition to taking the sprouts, participants will be asked to complete food diaries and surveys, collect blood and stool samples, as well as having 2 in-person visits.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

1 Serving of broccoli sprouts

Participants will take 1 serving of broccoli sprouts daily for 28 days. The sprouts will be provided by the study team along with instructions on how to prepare the steamed broccoli sprouts (i.e., steamed for 10 minutes). In addition to taking the sprouts, participants will be asked to complete food diaries and surveys, collect blood and stool samples, as well as having 2 in-person visits.

Intervention Type DIETARY_SUPPLEMENT

3 Servings of broccoli sprouts

Participants will take 3 servings of broccoli a day for 28 days. The sprouts will be provided by the study team along with instructions on how to prepare the steamed broccoli sprouts (i.e., steamed for 10 minutes). In addition to taking the sprouts, participants will be asked to complete food diaries and surveys, collect blood and stool samples, as well as having 2 in-person visits.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Documented endoscopic diagnosis of ulcerative colitis
* Currently being treated with a stable dose of 5-ASAs, steroids, or any other medication approved for ulcerative colitis

* If on 5-ASA, no dose changes within 2 weeks before the Day 0 visit
* If on steroids, prednisone dose not more than 20 mg daily and entocort not more than 9 mg daily, with no dose changes within 2 weeks before the Day 0 visit
* All other medications require a stable dose for at least 8 weeks prior to enrollment.
* No dose changes to any IBD medication anticipated for the duration of the study
* Body Mass Index (BMI) values 18.5-40 kg/m2
* Not on total parenteral nutrition (TPN) or receiving tube feeds.
* Ability to understand the study procedures, benefits and risks, and sign a written informed consent document.
* Able to fill out questionnaires regarding dietary intakes, bowel symptoms, and study experience

Exclusion Criteria

* Taking Non-steroidal anti-inflammatory drugs (NSAIDs)
* Following a medically-prescribed diet, on Total parenteral nutrition (TPN), or tube feeds
* Newly diagnosed (within past month), or uncontrolled diabetes or cardiovascular disease
* Antibiotics in the previous 2 weeks
* Consumption of more than 5 ½ cups of servings/day of fruits and vegetables as assessed by the National Cancer Institute (NCI) Diet History Questionaire III online Food Questionnaire.
* A known allergy or sensitivity to cruciferous vegetables like arugula, bok choy, broccoli, cabbage, cauliflower, or collard greens
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Maine

OTHER

Sponsor Role collaborator

University of Michigan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Grace Chen

Associate Professor of Internal Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Grace Chen

Role: PRINCIPAL_INVESTIGATOR

University of Michigan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Michigan

Ann Arbor, Michigan, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-67017-36303

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

HUM00210637

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dietary Treatment of Crohn's Disease
NCT00343642 COMPLETED PHASE1/PHASE2
Diet Study on Ulcerative Colitis
NCT04147598 COMPLETED NA
Treatment of UC With Novel Therapeutics
NCT06420375 RECRUITING PHASE2
Dried Chicory Root in IBD
NCT06016322 UNKNOWN NA
Treating IBD With Inulin
NCT03653481 COMPLETED NA